Veterinary Medicine Information website

BIOCAN NOVEL PUPPY, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims

Authorised
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live

Product identification

Medicine name:
BIOCAN NOVEL PUPPY, liofilizatas ir skiediklis injekcinei suspensijai ruošti šunims
Active substance:
  • Canine distemper virus, strain CDV Bio 11/A, Live
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
  • Canine distemper virus, strain CDV Bio 11/A, Live
    5.50
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AD03
Authorisation status:
  • Valid
Authorised in:
  • Lithuania

Additional information

Entitlement type:
  • Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • 2025-03-05 Nr. ĮV-1060
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
  • Bertas Nams SIA
Destination wholesaler:
  • Vetfarmas UAB